B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 600 KRW -2.13% Market Closed
Market Cap: 469.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Total Current Assets
â‚©456.5B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Current Assets
â‚©5T
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
20%
SK Bioscience Co Ltd
KRX:302440
Total Current Assets
â‚©1.4T
CAGR 3-Years
61%
CAGR 5-Years
50%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Current Assets
â‚©552.6B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Current Assets
â‚©312.1B
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Current Assets
â‚©180.7B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
469.5B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
6 138.02 KRW
Undervaluation 25%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Total Current Assets?
Total Current Assets
456.5B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Total Current Assets amounts to 456.5B KRW.

What is BioNote Inc's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
-7%

Over the last year, the Total Current Assets growth was -45%. The average annual Total Current Assets growth rates for BioNote Inc have been -7% over the past three years .

Back to Top